STRAGEN is an independent Swiss company founded in 1990, specialized in the development and commercialization of niche generic and generic+ pharmaceuticals, innovative consumer health products, and in the early-stage development of new drugs. STRAGEN also offers a range of specifically tailored consulting services for pharmacovigilance and clinical development strategies.
Development, registration, and supply of generic and generic+ products
Consulting services for pharmacovigilance and clinical development strategies and design
Development of innovative and clinically proven consumer health products
NEW DRUG DEVELOPMENT
From lab discovery to the clinical development of original, patented drugs with high therapeutic potential